Point Of Care Lipid Test Market To Reach $1,268.33 Million By 2033

Point Of Care Lipid Test Market Growth & Trends

The global point of care lipid test market size is estimated to reach USD 1,268.33 million by 2033, registering to grow at a CAGR of 6.05% from 2025 to 2033 according to a new report by Grand View Research, Inc. The rising prevalence of chronic conditions like cardiovascular diseases, diabetes, and kidney disorders is a key driver contributing to the market growth, as these conditions often necessitate frequent lipid monitoring for effective management. Cardiovascular complications remain a major concern for patients with kidney disease, where factors such as elevated lipid levels and systemic inflammation increase risks.

Furthermore, this trend aligns with the broader emphasis on preventive healthcare, where early detection of lipid imbalances helps mitigate long-term health risks. Portable testing devices enable real-time results at clinics, hospitals, or homes, streamlining patient care and empowering individuals to manage their health proactively. The integration of these tools with digital platforms supports remote monitoring, a practice that gained momentum during the pandemic and remains relevant for reducing unnecessary clinical visits.

 Request a free sample copy or view report summary: Point Of Care Lipid Test Market Report

Point Of Care Lipid Test Market Report Highlights

• Consumables dominated the product segment and accounted for the largest revenue share of 61.9% in 2024. This is attributed to the need for disposable and single-use consumables for rapid, user-friendly testing procedures.

• Instruments are expected to grow at a CAGR of 6.13% over the forecast period, owing to contemporary analyzers' improved accuracy, mobility, and connectivity features, which make them perfect for decentralized situations.

• Hypertriglyceridemia is expected to grow at a CAGR of 6.55% over the forecast period, owing to the rapid developments in testing technologies that improve speed and accessibility.

• Lipid and lipoprotein disorders dominated the market, with the largest revenue share of 38.7% in 2024. Atherosclerosis is expected to grow at a significant CAGR from 2025 to 2030.

• The hospitals segment held the dominant position in the market and accounted for the largest revenue share, 32.16%, in 2024. Hospitals need quick, precise lipid testing to allow appropriate diagnosis and management of chronic situations, enhancing patient outcomes.

• North Americadominated the global point-of-care lipid test market and accounted for the largest revenue share of 43.58% in 2024, primarily due to the incorporation of point-of-care testing with telehealth platforms, which improves user-friendliness and patient engagement.

Point Of Care Lipid Test Market Segmentation

Grand View Research has segmented the global point of care lipid test market based on product, application, disease indication, end use, and region:

Point of Care Lipid Test Product Outlook (Revenue, USD Million, 2021 - 2033)

• Instruments

• Consumables

Point of Care Lipid Test Application Outlook (Revenue, USD Million, 2021 - 2033)

• Hyperlipidemia

• Hypertriglyceridemia

• Tangier Disease

• Hyperlipoproteinemia

• Familial Hypercholesterolemia

• Others

Point of Care Lipid Test Disease Indication Outlook (Revenue, USD Million, 2021 - 2033)

• Lipid and Lipoprotein Disorders

• Atherosclerosis

• Liver and Renal Diseases

• Diabetes Mellitus

• Others

Point of Care Lipid Test End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Hospitals

• Clinics

• Research and Diagnostic Laboratories

• Others

Point of Care Lipid Test Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Point Of Care Lipid Test Market

• Callegari Srl

• Sinocare Inc.

• Abbott Laboratories

• MiCoBio

• Nova Biomedical

• VivaChek Biotech (Hangzhou) Co., Ltd.

• F. Hoffmann-La Roche Ltd.

• Menarini Group

• SD Biosensor, Inc.